DR. MICHAEL ANDREW ROGAWSKI, M.D.
Neurology at Y St, Sacramento, CA
License number
California G88105
Category
Neurology
Type
Neurology
Address
Address
4860 Y St SUITE 3700, Sacramento, CA 95817
Phone
(916) 734-6275
(916) 724-6526 (Fax)
(916) 724-6526 (Fax)
Personal information
See more information about MICHAEL ANDREW ROGAWSKI at radaris.comName
Address
Phone
2237 Sierra Blvd, Sacramento, CA 95825
Sacramento, CA
2237 Sierra Blvd, Sacramento, CA 95825
Professional information
Michael Andrew Rogawski, Sacramento CA
Specialties:
Neurology, Psychiatry
Work:
Ucdmc, Lawrence J. Ellison Ambulatory Care Center
4860 Y St, Sacramento, CA 95817
4860 Y St, Sacramento, CA 95817
Education:
Yale University (1980)
Dr. Michael A Rogawski, Sacramento CA - MD (Doctor of Medicine)
Specialties:
Neurology, Psychiatry
Address:
UC Davis Med Ctr Nrlgy Clin
4860 Y St SUITE 1100, Sacramento 95817
(916) 734-3588 (Phone)
4860 Y St SUITE 1100, Sacramento 95817
(916) 734-3588 (Phone)
Languages:
English
Education:
Medical School
Yale University
Graduated: 1980
Yale University
Graduated: 1980
Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties
US Patent:
8575375, Nov 5, 2013
Filed:
Jun 16, 2008
Appl. No.:
12/664470
Inventors:
Scott P. Runyon - Hillsborough NC, US
Michael A. Rogawski - Sacramento CA, US
John Kepler - Raleigh NC, US
Hernan Navarro - Chapel Hill NC, US
Rafal Kaminski - Waterloo, BE
Matthew Orr - Raleigh NC, US
Kevin M. Cook - Fairfax Station VA, US
Michael A. Rogawski - Sacramento CA, US
John Kepler - Raleigh NC, US
Hernan Navarro - Chapel Hill NC, US
Rafal Kaminski - Waterloo, BE
Matthew Orr - Raleigh NC, US
Kevin M. Cook - Fairfax Station VA, US
Assignee:
Research Triangle Institute - Research Triangle Park NC
The United States of America, as represented by the Secretary, Department of Health and Human Services - Washington DC
The United States of America, as represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
C07J 41/00
US Classification:
552522
Abstract:
This invention describes compounds of Structures 1, 2, and 3 and their use as allosteric modulators of the GABA receptor chloride ionophore complex to alleviate stress, anxiety, mood disorders, seizures, depression, treatment of drug and alcohol abuse, memory, premenstrual disorders, and neural system damage.
Apparatus And Methods For Treating Epilepsy Using Convection-Enhanced Delivery
US Patent:
2009020, Aug 20, 2009
Filed:
Aug 8, 2008
Appl. No.:
12/189063
Inventors:
Michael Andrew ROGAWSKI - Sacramento CA, US
Maciej GASIOR - Devon PA, US
Maciej GASIOR - Devon PA, US
Assignee:
ARGENIS LLC - Sacramento CA
International Classification:
A61M 5/168, A61K 38/17, A61K 39/08, A61K 31/421, A61K 9/127, A61M 5/14
US Classification:
604503, 514 12, 4242391, 514376, 424450, 604506
Abstract:
Disclosed herein are apparatuses and methods for treating a neurological disorder associated with excessive neuronal excitability (e.g., epilepsy). Methods disclosed herein comprise administering to a subject in need of such treatment an antiepileptic drug solution comprising a therapeutically effective amount of an antiepileptic drug (e.g., a toxin that inhibits the exocytosis of neurotransmifters, excitotoxins, etc.) using convection-enhanced delivery (CED).
Intrapulmonary Benzodiazepine For The Treatment And Prevention Of Seizures
US Patent:
2013030, Nov 21, 2013
Filed:
Dec 1, 2011
Appl. No.:
13/885660
Inventors:
Michael A. Rogawski - Sacramento CA, US
Ashish Dhir - Sacramento CA, US
Ashish Dhir - Sacramento CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 9/00, A61K 31/5517
US Classification:
424489, 514220
Abstract:
This invention provides methods for the amelioration, termination and/or abortion of a seizure by the intrapulmonary administration of a benzodiazepine, for example, midazolam.